New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 27, 2014
09:55 EDTOPKOPKO Health granted Lagova patent in Europe
OPKO Health announced that the European Patent Office granted OPKO a patent covering the company’s long-acting CTP-enhanced human growth hormone product Lagova, including composition of matter and associated methods.
News For OPK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 29, 2015
14:43 EDTOPKOPKO Health reports submission of Rayaldee NDA to FDA
OPKO Health announced that it has submitted a New Drug Application, or NDA, for oral Rayaldee to the FDA. The NDA requests marketing approval for Rayaldee for the prevention and treatment of secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use